IPT during HIV treatment in Myanmar: high rates of coverage, completion and drug adherence
Isoniazid preventive therapy (IPT) in one of the last countries to formally recommend it as part of HIV care
Abstract
A southern Myanmar district providing isoniazid preventive therapy (IPT) in one of the last countries to formally recommend it as part of human immunodeficiency virus (HIV) care.
Objective of the study is to assess coverage and adherence and the feasibility of IPT scale-up in a routine care setting in Myanmar. Design: A retrospective analysis of people living with HIV (PLHIV) screened for tuberculosis (TB) and enrolled in IPT over a 3-year period (July 2011–June 2014) using clinical databases.
This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)
Citation
Ousley J, Soe KP, Kyaw NTT, Anicete R, Mon PE, Lwin H, Win T, Cristofani S, Telnov A, Fernandez M, Ciglenecki I. IPT during HIV treatment in Myanmar: high rates of coverage, completion and drug adherence. Public Health Action. 2018;8(1):20–4.
Links
IPT during HIV treatment in Myanmar: high rates of coverage, completion and drug adherence